A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The CELT ACD trial.

Shing Chiu WongMichael LauleZoltan G TuriWasiem SanadJames CrowleyHubertus DegenKathleen BennettJim E ColemanGeoffrey Bergman

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)

After 6-F percutaneous invasive procedures in fully anticoagulated patients, TTH was significantly reduced in patients assigned to Celt ACD® compared to patients managed with MC. The 30-day rates of vascular complications were similarly low in both groups. (CELT ACD Trial; NCT01600482) © 2017 Wiley Periodicals, Inc.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
clinical trial
peritoneal dialysis
prognostic factors
randomized controlled trial
heart failure
study protocol
patient reported outcomes
coronary artery disease
ultrasound guided
risk factors
left ventricular
open label